Last reviewed · How we verify
Immediate-release metronidazole — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Immediate-release metronidazole (Immediate-release metronidazole) — Gateway Pharmaceutical LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Immediate-release metronidazole TARGET | Immediate-release metronidazole | Gateway Pharmaceutical LLC | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Immediate-release metronidazole CI watch — RSS
- Immediate-release metronidazole CI watch — Atom
- Immediate-release metronidazole CI watch — JSON
- Immediate-release metronidazole alone — RSS
Cite this brief
Drug Landscape (2026). Immediate-release metronidazole — Competitive Intelligence Brief. https://druglandscape.com/ci/immediate-release-metronidazole. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing